search
Back to results

The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy

Primary Purpose

Keratosis, Actinic

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Microneedle Roller
Aminolevulinic Acid
Blue Light
Sponsored by
University of California, Davis
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Keratosis, Actinic

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years of age and older
  • Subjects has actinic keratoses and qualifies for photodynamic therapy
  • Do not meet any of the exclusion criteria

Exclusion Criteria:

  • Subjects who smoke
  • Subjects who have a photosensitizing condition such as lupus, porphyria, or similar condition
  • Subjects who have established allergy to topical ALA
  • Subjects who have had a documented nonmelanoma skin cancer on the face over the past 6 months

Sites / Locations

  • University of California-Davis, Department of Dermatology

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

10-minute Incubation with Microneedle Roller & Sham

20-minute Incubation with Microneedle Roller & Sham

Arm Description

10-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.

20-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.

Outcomes

Primary Outcome Measures

Difference in the Percentage of Complete Clearance of the Actinic Keratoses
The primary endpoint will be the difference in the percentage of complete clearance of the actinic keratoses as an intraindividual comparison between the treatment groups.

Secondary Outcome Measures

Visual Analog Pain Scale
The secondary will be any pain associated with the microneedle pretreatment and with the application of the PDT using the 100 mm Visual Analog Scale pain grading. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

Full Information

First Posted
October 31, 2015
Last Updated
October 30, 2018
Sponsor
University of California, Davis
search

1. Study Identification

Unique Protocol Identification Number
NCT02594644
Brief Title
The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy
Official Title
The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
October 2018
Overall Recruitment Status
Completed
Study Start Date
November 6, 2014 (Actual)
Primary Completion Date
June 22, 2016 (Actual)
Study Completion Date
June 22, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, Davis

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to investigate how varying incubation periods of topical aminolevulinic acid after pretreatment with microneedle application can facilitate the penetration and efficacy of photodynamic therapy.
Detailed Description
The current standard of care of photodynamic therapy to treat actinic keratoses includes pre-treatment of the area with topical aminolevulinic acid for 1 hour, followed by treatment with blue light. In a previous study, the investigators showed pretreatment of microneedles enhance penetration of topical aminolevulinic acid as compared to the control group. The aim of this study is to investigate how varying incubation periods of topical aminolevulinic acid after pretreatment with microneedle application can facilitate the penetration and efficacy of photodynamic therapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Keratosis, Actinic

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
32 (Actual)

8. Arms, Groups, and Interventions

Arm Title
10-minute Incubation with Microneedle Roller & Sham
Arm Type
Experimental
Arm Description
10-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.
Arm Title
20-minute Incubation with Microneedle Roller & Sham
Arm Type
Experimental
Arm Description
20-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.
Intervention Type
Device
Intervention Name(s)
Microneedle Roller
Intervention Description
The study device (MR200, Clinical Resolutions Laboratory, Inc.) is a disposable roller equipped with stainless steel needles that are 650 micrometers in length.
Intervention Type
Drug
Intervention Name(s)
Aminolevulinic Acid
Intervention Description
Levulan® Kerastick® DUSA Pharmaceuticals, Inc., Wilmington, MA
Intervention Type
Radiation
Intervention Name(s)
Blue Light
Intervention Description
Blu-U unit (DUSA Pharmaceuticals, Inc., Wilmington, MA
Primary Outcome Measure Information:
Title
Difference in the Percentage of Complete Clearance of the Actinic Keratoses
Description
The primary endpoint will be the difference in the percentage of complete clearance of the actinic keratoses as an intraindividual comparison between the treatment groups.
Time Frame
Baseline, 2 Months
Secondary Outcome Measure Information:
Title
Visual Analog Pain Scale
Description
The secondary will be any pain associated with the microneedle pretreatment and with the application of the PDT using the 100 mm Visual Analog Scale pain grading. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.
Time Frame
Immediately Post-Treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years of age and older Subjects has actinic keratoses and qualifies for photodynamic therapy Do not meet any of the exclusion criteria Exclusion Criteria: Subjects who smoke Subjects who have a photosensitizing condition such as lupus, porphyria, or similar condition Subjects who have established allergy to topical ALA Subjects who have had a documented nonmelanoma skin cancer on the face over the past 6 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Raja Sivamani, M.D.
Organizational Affiliation
University of California, Davis
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California-Davis, Department of Dermatology
City
Sacramento
State/Province
California
ZIP/Postal Code
95816
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
28514458
Citation
Petukhova TA, Hassoun LA, Foolad N, Barath M, Sivamani RK. Effect of Expedited Microneedle-Assisted Photodynamic Therapy for Field Treatment of Actinic Keratoses: A Randomized Clinical Trial. JAMA Dermatol. 2017 Jul 1;153(7):637-643. doi: 10.1001/jamadermatol.2017.0849.
Results Reference
derived

Learn more about this trial

The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy

We'll reach out to this number within 24 hrs